Michael Kometer

Cellular and Molecular Neuroscience · 2010

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom Michael Kometer trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Husseini K. Manji

Who trusts Michael Kometer overall

  1. M. Bogenschutz

Papers from Michael Kometer's perspective

Ordered by how strongly the researchers Michael Kometer trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. (Biological Psychiatry)
  2. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders (Nature reviews. Drug discovery)
  3. New insights into BDNF function in depression and anxiety (Nature Neuroscience)
  4. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. (Archives of General Psychiatry)
  5. Antidepressant effects of ketamine in depressed patients. (Biological Psychiatry)
  6. NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons (Journal of Neuroscience)
  7. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus (Nature Neuroscience)
  8. Failure to Regulate: Counterproductive Recruitment of Top-Down Prefrontal-Subcortical Circuitry in Major Depression (Journal of Neuroscience)
  9. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (Psychopharmacology)
  10. Untreated depression and hippocampal volume loss. (American Journal of Psychiatry)

Their papers